International MG/COVID-19 Working Group, Jacob, S., Muppidi, S., Guidon, A., Guptill, J., Hehir, M., … Nowak, R. J. (2020). Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci, 412, 116803. https://doi.org/10.1016/j.jns.2020.116803

International MG/COVID-19 Working Group, Saiju Jacob, Srikanth Muppidi, Amanda Guidon, Jeffrey Guptill, Michael Hehir, James F. Howard, et al. “Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.” J Neurol Sci 412 (May 15, 2020): 116803. https://doi.org/10.1016/j.jns.2020.116803.

International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 May 15;412:116803.

International MG/COVID-19 Working Group, et al. “Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.” J Neurol Sci, vol. 412, May 2020, p. 116803. Pubmed, doi:10.1016/j.jns.2020.116803.

International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF, Illa I, Mantegazza R, Murai H, Utsugisawa K, Vissing J, Wiendl H, Nowak RJ. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020 May 15;412:116803.